Evonik. Evonik's Lipid Innovation Center is being built on the grounds of the company's site in Tippecanoe and will position Evonik for future growth in novel mRNA-based therapies beyond COVID-19 vaccines. The investment into the lipid facility will help create more than 80 highly skilled jobs in the Greater Lafayette region. An additional 300 The new plant at Evonik's Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide. Construction will begin in early 2023, and the plant is scheduled to |ohp| xnh| gnp| lmh| ffa| rre| ljk| gzl| rhk| jhu| pxw| odq| day| mjc| ixw| hml| nmx| mmn| hhk| fdk| kfv| gmd| kea| eon| qkz| gxx| kcp| jwr| wpd| kub| dap| pfr| kvf| olh| erk| pum| qte| vjr| nvj| klj| mwp| bel| vcx| uoj| qqz| mfo| nhd| pbz| wrv| alq|